Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial
- Resource Type
- Article
- Source
- In
Vaccine 6 April 2023 41(15):2553-2561 - Subject
- Language
- ISSN
- 0264-410X